RESEARCH DATABASE

InBody Scholar

InBody continues to work closely with academic researchers on a global scale to develop more in-depth clinical applications of body composition. With our long history in the industry, we provide more than 7,000 research publications.

Printable list of studies

Use the search box below to find key terms in research papers. For category-specific or recommended results, use the dropdown lists provided.
Research title with ★ indicates InBody recommended paper.

Dapagliflozin significantly reduced liver fat accumulation associated with a decrease in abdominal subcutaneous fat in patients

Endocrinology
Author
Kurinami N et al.
Used Parameters : FM, PBF

Publication Year : 2018

Country : Japan

Journal : Diabetes Research and Clinical Practice

Aims We examined dapagliflozin-induced changes in liver fat accumulation. Methods We prospectively recruited Japanese patients with inadequately controlled type 2 diabetes mellitus (T2DM)[hemoglobin A1c (HbA1c)> 7.0%]. Dapagliflozin (5 mg/day) or non-sodium glucose cotransporter 2 inhibitors (SGLT2i) was added to the patients' treatment regimen for 6 months. Changes in liver fat accumulation were assessed by the liver-to-spleen (L/S) attenuation ratio using abdominal computed tomography (CT). Results This study enrolled …
Full text